Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 16 papers were listed this time. Here's a handful:
Chow IH, Tang CH, You SL, et al. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system. Br J Cancer. 2010 Nov 23. [Epub ahead of print] PMID: 21102588
Kozminski MA, Neumann PJ, Nadler ES, et al. How Long and How Well: Oncologists' Attitudes Toward the Relative Value of Life-Prolonging v. Quality of Life-Enhancing Treatments. Med Decis Making. 2010 Nov 18. [Epub ahead of print] PMID: 21088130
Baeten SA, van Exel NJ, Dirks M, et al. Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach. Cost Eff Resour Alloc. 2010 Nov 17;8(1):21. [Epub ahead of print] PMID: 21083901
Kondo M, Hoshi SL, Yamanaka T, et al. Economic evaluation of the 21-gene signature (Oncotype DX(®)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03). Breast Cancer Res Treat. 2010 Nov 17. [Epub ahead of print] PMID: 21082239